医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Navient Neuro-navigation System Receives Chinese Regulatory Clearance

2021年12月17日 AM03:00
このエントリーをはてなブックマークに追加


 

TORONTO

ClaroNav Kolahi Inc, a subsidiary of ClaroNav Inc, is pleased to announce that it has received Chinese regulatory clearance from the National Medical Products Administration (NMPA) to market and sell its Navient Cranial model in China. Previously it had received NMPA approval for Navient ENT model.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211216005914/en/

Navient neuro-navigation system (Photo: Business Wire)

Navient neuro-navigation system (Photo: Business Wire)

Navient, an image-guided surgical navigation system, is like a GPS for the surgeon to navigate inside the patient skull. It provides three-dimensional visualization and assists surgeons with finding their ways inside the patient skull navigating their way safely to the diseased area.

“Navient is an innovative image-guided surgical navigation system offering an intuitive software workflow, accurate navigation, reliable hardware in an elegant and portable design. The product is well aligned with our corporate strategy of benefiting Chinese patients and surgeons with advanced technologies.” Said Mr. Pan Wang, CEO at Nanning Xinzizhu Trading Co., Ltd., Navient’s exclusive distributor in China. “We are very excited in receiving Chinese NMPA approval and looking forward to further expanding our activities in China to provide the best service and support to our customers.”

“Chinese NMPA approval opens a significant market to Navient. We are thrilled that our Navient product now has regulatory approval from all major regulatory agencies including US FDA, European CE, Health Canada, Korean MFDS, Brazilian ANVISA and Taiwan FDA.” said Ahmad Kolahi, CEO of CKI “Navient has been designed with simplicity and ease of use in mind. The result is a product that enables the surgeons to operate the system more confidently and accurately. We are looking forward to working with our partner in China and making image-guided surgery standard-of-care in China.”

Additional information: www.claronav.com/navient

About ClaroNav Inc.

ClaroNav is a medical device hardware and software company focused on surgical navigation headquartered in Toronto, Canada, and is represented worldwide by authorized distributors. ClaroNav is dedicated to innovation and developing state-of-the-art surgical navigation systems.

About Nanning Xinzizhu Trading Co. Ltd (XZZ)

XZZ is Navient’s exclusive distributor in China headquartered in Nanning, China. XZZ’s is focused on improving medical conditions in China by importing innovative and state-of-the-art international medical devices. XZZ’s covers over 20 provinces and services more than 50 hospitals.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211216005914/en/

CONTACT

ClaroNav Inc.

Phone: + 1 (647) 951 1525

Website www.claronav.com

Email: info@claronav.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • メアリー・ケイ、米国栄養学会の年次総会で植物葉エキスの効能に関する新たな研究結果を発表
  • ENHERTU® Approved in the EU as the First HER2 Directed Therapy for Patients with HER2 Low Metastatic Breast Cancer
  • PHCの遠隔医療システム「Teladoc HEALTH」がシェアメディカルのデジタル聴診デバイス「ネクステート」と接続 ~ 接続機器の拡充により遠隔聴診を実現 ~
  • Latest Clinical Data of InnoCare’s Gunagratinib Presented at 2023 ASCO GI
  • Imricor Collaborates with GE HealthCare in Interventional Cardiac MRI